Back
Brookfield Infrastructure Corp. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
71
BIPC
Brookfield Infrastructure Corp.
Last Price:
$46.35
Seasonality Move:
2.64%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$89.66
Seasonality Move:
10.35%
Buy
71
Brookfield Infrastructure Corp. (BIPC)
is a Buy
Is Brookfield Infrastructure Corp. a Buy, Sell or Hold?
-
The current Brookfield Infrastructure Corp. [BIPC] share price is $46.77. The Score for BIPC is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
BIPC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
BIPC Stock Price Chart
What is Brookfield Infrastructure Corp.'s stock price today?
-
The Brookfield Infrastructure Corp. share price today is $46.77The current trend is moderately bullish and BIPC is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $87.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
BIPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 58.72 | Buy |
| Chaikin Money Flow: | -327716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.62 - 46.52) | Buy |
| Bollinger Bands (100): | (40.02 - 45.42) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.53 | Buy |
| Relative Strength Index (14 RSI): | 71.11 | Buy |
| Chaikin Money Flow: | -592960 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.18 - 78.14) | Buy |
| Bollinger Bands (100): | (43.11 - 66.09) | Buy |
BIPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.66 | Buy |
| 20-day SMA: | 45.6 | Buy |
| 50-day SMA: | 45.24 | Buy |
| 200-day SMA: | 40.67 | Buy |
| 8-day EMA: | 46.44 | Buy |
| 20-day EMA: | 45.89 | Buy |
| 50-day EMA: | 44.84 | Buy |
| 200-day EMA: | 41.94 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.75 | Buy |
| 20-day SMA: | 70.43 | Buy |
| 50-day SMA: | 63.87 | Buy |
| 200-day SMA: | 45.05 | Buy |
| 8-day EMA: | 80.77 | Buy |
| 20-day EMA: | 72.92 | Buy |
| 50-day EMA: | 64.9 | Buy |
| 200-day EMA: | 50.57 | Buy |
Brookfield Infrastructure Corp. Earnings Growth & BIPC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and an increase next year of $8.50 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.
Brookfield Infrastructure Corp. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||